Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024

United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

FREE | Request an Overview @ https://mnemonicsresearch.com/request-an-overview/flu-vaccine-market-0059

Long–term Growth Projection and Development:

• Sanofi to Acquire Protein Sciences Corporation
• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024
• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

Request for Proposal @ https://mnemonicsresearch.com/submit-rfp/flu-vaccine-market-0059

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Key Topics Covered in the Report

• Market Overview: United States Flu Vaccine Market (2010 – 2024)
• United States Number of Persons Vaccinated with Flu Vaccine (2010 – 2024)
• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
• Reimbursement & Regulatory System in the US Flu Vaccine Market
• Mergers, Acquisitions, Key Agreements & Collaborations
• Promising Flu Vaccine in Clinical Development
• Flu Vaccine Clinical Trial Insights by Phase, Company & Country
• Key Drivers and Inhibitors of the US Flu Vaccine Market
• Key Companies Analysis

Major Flu Vaccines Covered Under This Report Are:

• Fluzone High–Dose
• Fluzone Quadrivalent
• Intradermal (ID) Trivalent
• Vaxigrip
• Fluarix Quadrivalent
• Flulaval Quadrivalent
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Agrippal
• Fluad
• Fluvirin
• Fluvax

Browse Full Report @ https://mnemonicsresearch.com/flu-vaccine-market-0059

Key Companies Covered in This Report:

• Seqirus
• Sanofi Pasteur
• GlaxoSmithKline(GSK)

Influenza Vaccines Market in Top 5 European Countries to 2022 – Market Size, Development and Forecasts

Influenza Vaccine Market is expected to reach more than US$ 1 Billion across the 5 major markets (5MM) of the France, Germany, Italy, Spain and United Kingdom by the year end of 2022.

FREE | Request an Overview @ https://mnemonicsresearch.com/request-an-overview/europe-influenza-vaccines-market-0042

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against Influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries.

United Kingdom influenza vaccine market is the most attractive of those covered in the report. The United Kingdom market for influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Germany will be the second–largest market for influenza vaccine which is expected to grow at a CAGR of XX% by 2022. France is expected to be third largest influenza vaccine market being followed by Italy by the end of the forecasted period.

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

Request for Proposal @ https://mnemonicsresearch.com/submit-rfp/europe-influenza-vaccines-market-0042

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into influenza vaccine sales forecast for the top five countries, comprising the UK, France, Italy, Spain and Germany until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players

in the influenza vaccine market, such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of influenza vaccine market.

Five Major European Markets(5MM) covered in the report are as follows:

1. United Kingdom
2. France
3. Italy
4. Spain
5. Germany

Browse Full Report @ https://mnemonicsresearch.com/europe-influenza-vaccines-market-0042

Major and Promising Vaccines covered in the report are as follows:

1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
16. Agrippal
17. Fluad
18. Fluvirin
19. Fluvax

Key Companies Covered in the Report are as follows:

1. Sanofi Pasteur
2. GlaxoSmithKline(GSK)
3. Seqirus
4. AstraZenecca
5. Protein Sciences Corporation
6. Novavax
7. Daiichi–Sankyo
8. Mitsubishi Tanabe Pharma
9. BiondVax Pharmaceuticals Ltd
10. VaxInnate

Lab Automation Market – Global Industry Analysis and Opportunities Assessment 2012 – 2022

Automation is one of the best weapon in the life science laboratory due to the growing demands for productivity in speed, accuracy, throughput and efficiency. Helped by advance technology, contemporary automated systems are already adept of a wide range of functions that were previously performed by slow, tedious and manual labor. Instrumentation continues to evolve, and is poised to tackle tasks that were not even conceivable just a few years ago. Originally used mostly by the big pharmaceutical and biotechnology companies, laboratory automation technology has quickly developed to satisfy a larger pool of clinical experts in the life science industry. Automation companies not only produce automation for specific customer needs but also smaller, easy-to-use systems that are much more accessible to clinical experts to satisfy their general needs. It is likely that Lab Automation market will reach more than US$ 16 Billion by the year 2022.

FREE | Request an Overview @  https://mnemonicsresearch.com/request-an-overview/lab-automation-market-0021

Clinical Automation Laboratory Market Analysis: In the clinical automation laboratory market, United States is seen as the dominant player followed by Europe and Japan will likely become second and third largest market. In terms of application, Work Station and LIMS are the leading market share taker in clinical laboratory automation market. It is anticipated that work station will lead the clinical lab automation market by the year 2022 followed by LIMS in 2nd position. Other applications of clinical lab automation such as sample transport system and specimen handling system will spot in 3rd and 4th position in clinical laboratory automation market.

Drug Discovery Automation Market Analysis: In the drug discovery automation market, United States is the hub for drug discovery. In 2015, United States hold XX% share of drug discovery automation market, which is expected to increase XX% by the year 2022. In terms of application, Plate readers has emerged as the largest market share taker in the drug discovery automation market followed by automated liquid system.

DPI Research report titled “Lab Automation Market – Global Industry Analysis and Opportunities Assessment 2012 – 2022” presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product types and major deals in the Lab Automation Industry.

Request for Proposal @ https://mnemonicsresearch.com/submit-rfp/lab-automation-market-0021

Lab Automation Market has been analysed from 3 viewpoints:

1) Market and Forecast (2012 – 2022)
2) Segment wise Market & Forecast (2012 – 2022)
4) Region wise Lab Automation Market & Forecast (2012 – 2022)

Lab Automation Market – Application Segments Covered in the Report are:

1. Clinical Automation Laboratory
2. Drug Discovery Automation

The following segments of the Clinical Automation Laboratory market are detailed with size and six year forecast.

• Work Station
• Sample Transport System
• Storage Retrieval System
• Specimen Handling System
• Laboratory Information Management System (LIMS)

Furthermore, the following segments of the Drug Discovery Automation market are detailed with size and six year forecast.

• Automated Liquid Handling System
• Robotics
• Plate Readers
• Dissolution Testing
• Storage Retrieval System
• Laboratory Information Management System (LIMS)

Browse Full Report @ https://mnemonicsresearch.com/lab-automation-market-0021

The report analyses the market based on regions and presents the forecast in terms of value for the next six years. Regions covered in the report include:

• United States
• Europe
• Japan
• Brazil, Russia, India, China(BRIC)
• Rest of the world

Data Sources

The information contained in this report is based on both primary and secondary sources.

Primary Sources: Questionnaires, Surveys, telephonic interviews with industry experts and Observations

Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, Newspapers, Books, Government official websites and other paid database sources.

United States vaccines market is poised to reach a value of more than US$ 26 billion by 2026

“United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and Forecast to 2026” provides a comprehensive analysis of the fast-evolving, high-growth united states vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the united states vaccines market. The report provides historical market data for 2015 – 2018, and forecasts from 2019 till 2026.

FREE | Request an Overview @ https://mnemonicsresearch.com/request-an-overview/united-states-vaccines-market-0113

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2026.The report provides clear insight into current and future developments of the united states vaccines market. The report also explores the detailed analysis of the leading 27 vaccines market assessments in the United States from 2015 to 2018 and forecasts to 2026. A comprehensive analysis has been done on market share with percentage of the leading 27 vaccines. The report also details the latest information about the vaccine’s pricing trends and regulatory framework of the United States vaccine market.

Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2026.

The report concludes with the profiles of the key players in the united states vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, and recent development.

Request for Proposal @ https://mnemonicsresearch.com/submit-rfp/united-states-vaccines-market-0113

The major companies dominating this market for its products, services, and continuous product developments are:

• Pfizer
• Merck
• Sanofi Pasteur
• Grifols
• GlaxoSmithKline (GSK)
• Dynavax Technologies Corporation

The following 27 leading vaccines of the united states vaccines market are detailed with market size and seven-years forecast

• Prevnar / Prevnar 13
• Gardasil / Gardasil 9
• Fluzone
• Flublok
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Fluad
• Varivax
• Menactra
• Proquad
• Pneumovax 23
• Fluarix/FluLaval
• Havrix/Twinrix/Engerix–B
• M–M–R II
• Adacel
• Boostrix
• Bexsero
• Menveo
• Trumenba
• Shingrix
• Pentacel
• Recombivax HB
• Rotateq
• Rotarix
• Pediarix/Infanrix
• Heplisav–B
• TDVAX

Browse Full Report @ https://mnemonicsresearch.com/united-states-vaccines-market-0113

Key Topics Covered in the Report:

• The Market Size of the United States Vaccines Market with Seven Years Forecast
• The Market Size of the 27 Leading Vaccines with Seven Years Forecast
• Thoroughly Evaluates Market Share of the 27 Leading Vaccines in the US Vaccines Market
• Provides Comprehensive Insights on the Latest Vaccines Pricing Trends and Analysis
• Detailed Insights of the Regulatory Framework of the US Vaccines Market
• Investigates the Key Growth Drivers and Restraints of the United States Vaccines Market
• Provides Key Trends with Respect to Collaboration, Partnerships, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement
• A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, and Recent Development

The Report Helps Answer the Following Questions:

• What is the current size of the overall united states vaccines market? How much will this market be worth from 2019 to 2026?
• What are the leading vaccines? What are their revenue potentials to 2026?
• Which vaccine provides highest market share?
• What are the main drivers and restraints in the united states vaccines market?
• What are the major deals happenings in the vaccines market?
• What are the united states vaccines pricing trends and analysis?
• What are the various vaccines available in the United States?
• Who are the leading companies and what are their activities, promising vaccines in the clinical development, recent developments, and prospects?

Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential

The United States influenza vaccines market size is anticipated to observe tremendous growth projections during 2019 – 2025.

FREE | Request an Overview @ https://mnemonicsresearch.com/request-an-overview/united-states-influenza-vaccines-market-0111

The prominent factors that are expected to contribute to the growth of the US Influenza vaccines market during the forecast period:

• Increased Disease Awareness
• Approval/launches of the New Influenza Vaccines
• Expanded Recommendations by Governmental and Advisory Bodies to be Vaccinated against Influenza Vaccines
• Introduction of the Quadrivalent Influenza Vaccines

Highlighted with 17 tables and 16 figures, this 145-page report“Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” is based on comprehensive research of the entire United States influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States influenza vaccines market. The report provides historical market data for 2013-2018, and forecasts from 2019 till 2025.

Request for Proposal @ https://mnemonicsresearch.com/submit-rfp/influenza-vaccines-market-0099

The report contains a deep analysis of the US influenza vaccines market with size in terms of both value and volume of the US influenza vaccines market. The report provides clear insight into current and future developments of the United States influenza vaccines market. The report also explores detailed analysis of the children and adults vaccinated with influenza vaccines in United States from 2013 to 2018 and forecasts to 2025. The report also details the latest information about the influenza vaccines production, supply, and allocation by major companies in the United States.

A comprehensive analysis has been done on pricing, distribution & demand and effectiveness of the influenza vaccines in the United States. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Furthermore, this topical report describes the features reimbursement pattern and offers a clear view of the regulatory framework. Additionally, the report comprises assessment of clinical trials, reviews promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025.

The report also provides comprehensive profiles of the dominant players in the country’s influenza vaccines market such as Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and AstraZeneca with important details on companies’ vaccines portfolio, sales, strategies, and the latest developments. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, and Biondvax Pharmaceuticals Ltd, are making novel technology-based influenza vaccines which are likely to affect the market share during the forecast period.

Browse Full Report @ https://mnemonicsresearch.com/influenza-vaccines-market-0099

Key Topics Covered in the Report:

• The Market Size of the United States Influenza Vaccines Market
• Scrutinizes the US Overall Persons Being Vaccinated with Influenza Vaccines
• Scrutinizes the US Children Being Vaccinated with Influenza Vaccines
• Scrutinizes the US Adults Being Vaccinated with Influenza Vaccines
• Provides Comprehensive Insights on the Latest Pricing Trends and Analysis
• Includes a Detailed Analysis of the US Influenza Vaccines Production, Supply, and Allocation (By Companies)
• Delivers a Complete Overview of the US Influenza Vaccines Distribution and Demand
• Examines the Effectiveness of the Influenza Vaccines in the United States
• Detailed Assessment of the Rapid Diagnostic Testing for the Management of Influenza
• Thoroughly Evaluates of the Distribution Channel and Technique of the Influenza Vaccination in the United States
• Detailed Insights of the Regulatory Framework, Features Reimbursement Patterns of the US Influenza Vaccines
• Provides Key Trends with Respect to Collaboration, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement
• An Insightful Analysis of the Promising Influenza Vaccines in the Clinical Development
• Reviews Most Recent Clinical Trials of the Influenza Vaccines
• Investigates the Key Growth Drivers and Restraints of the US Influenza Vaccines Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development

The Report Helps Answer the Following Questions:

• What is the size of the influenza vaccines market in the United States?
• How many persons being vaccinated with influenza vaccines in the US during 2013 – 2025?
• What are the key drivers and restraints in the current market?
• What are the various influenza vaccines available in the United States?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?

Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development.

FREE | Request an Overview @ https://mnemonicsresearch.com/request-an-overview/pediatric-vaccines-market-0076

“Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025”provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decision–making. This report recognizes that in this rapidly–evolving and competitive environment, up–to–date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on United States pediatric vaccines market. The report also provides clear insight into current and future developments of the United States pediatric vaccines market. Further more, this report provides a deep and thorough evaluation of the top 10 pediatric Vaccines by disease indication. On the basis of disease indication, the top 10 pediatric Vaccines provide an in-depth analysis of doses administered number of children being vaccinated and market size. The research includes historic data from 2010 to 2017 and forecasts until 2025.

The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccines market.

Request for Proposal @  https://mnemonicsresearch.com/submit-rfp/pediatric-vaccines-market-0076

The report concludes with the profiles of major players in the United States pediatric vaccines market. The key market players are evaluated on various parameters such as company overview, pediatric vaccines portfolios and latest development & trends of the pediatric vaccines market.

The Major Companies dominating this Market for its Products, Services and Continuous Product Developments are:

• Sanofi Pasteur
• GlaxoSmithKline(GSK)
• Merck & Co.
• Pfizer Inc
• Grifols

Major Pediatric Vaccines (Disease Indication) Covered Under This Report are:

• Diphtheria, Tetanus & Pertussis (DTap)
• Hepatitis A
• Varicella/Chicken Pox
• Pneumococcal
• Haemophilus Influenzae Type B (HIB)
• Polio
• Rotavirus
• Hepatitis B
• Influenza Pediatric
• Measles, Mumps & Rubella (MMR)

Browse Full Report @ https://mnemonicsresearch.com/pediatric-vaccines-market-0076

The Latest Industry Data Included in this Report:

• United States Pediatric Vaccines Market Size & Analysis ,2010 – 2025
• United States Pediatric Vaccines Market Share and Y–o–Y Growth (%),2010 – 2025
• United States Pediatric Vaccines Market by Disease Indication ,2010 – 2025
• 10 Pediatric Vaccines Doses Administered (Volume),2010 – 2025
• Number of Children Being Vaccinated (Volume)2010 – 2025
• 10 Pediatric Vaccines Market Size and Forecast(Value),2010 – 2025
• Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Product Portfolios and Latest Recent Development and Trends

The following key questions have been addressed in the report:

• What is the size of the United States pediatric vaccines market during 2010 -2025?
• How will each segment of the United States pediatric vaccines market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2025?
• Which major pediatric vaccines provides highest market share?
• How much number of children being vaccinated during 2010-2025?
• How are the overall market and segments types growing?
• What are the major market drivers and inhibitors in the United States pediatric vaccines market?
• Who are the key players in the United States pediatric vaccines market and what are their contributions?

United States Pediatric Vaccine market is likely to reach nearly US$ 10 Billion by 2024.

Growth in US pediatric vaccine market can be attributed to factors such as increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccine development.

FREE | Request an Overview @ https://mnemonicsresearch.com/request-an-overview/united-states-pediatric-vaccine-market-0063

The research report titled “United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States pediatric vaccine market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues and provides forecasts through 2024. The report also provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccine market.

The report concludes with the profiles of major players in the United States pediatric vaccine market. The key market players are evaluated on various parameters such as company overview, pediatric vaccine portfolios and latest development & trends of the pediatric vaccine market.

Request for Proposal @ https://mnemonicsresearch.com/submit-rfp/united-states-pediatric-vaccine-market-0063

Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:

Diphtheria, Tetanus & Pertussis (DTap)
Hepatitis A
Varicella/Chicken Pox
Pneumococcal
Haemophilus Influenzae Type B (HIB)
Polio
Rotavirus
Hepatitis B
Influenza Pediatric
Measles, Mumps & Rubella (MMR)

Browse Full Report @ https://mnemonicsresearch.com/united-states-pediatric-vaccine-market-0063

Key Companies Covered in the Report are as follows:

Sanofi Pasteur
GlaxoSmithKline(GSK)
Merck & Co.
Pfizer Inc
Grifols

Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
It provides a growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed based on how the market is predicted to grow
It helps in understanding the key product segments and their future
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
A comprehensive list of key market players along with the analysis of their current pediatric vaccines portfolios and latest development and trends.

Zika Virus Vaccines by Company Profile, Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development

It is predicted that Zika virus vaccines shot will available to the public by 2018.

Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar epidemiology, clinical presentation and transmission cycle in urban environments as chikungunya and dengue, although it generally causes milder illness.

FREE | Request an Overview @ https://mnemonicsresearch.com/request-an-overview/zika-virus-vaccines-market-0043

The highest risk is to pregnant women due to the connection the virus has with serious birth defects. Pregnant women who contract the virus have a high possibility of giving birth to a baby with microcephaly, a neurodevelopment disorder, where a baby is born with an unusually small head due to abnormal brain development in the womb or after birth. Complications of this disorder include seizures and developmental issues.

Due to the serious nature of global risk, the WHO has declared the microcephaly cases associated with the Zika virus a Public Health Emergency of International Concern (PHEIC). With no vaccines or cure the virus and its risks are expected to continue to spread. The WHO is predicting up to 4 Million Zika cases in the Americas by 2016 and the World Bank is projecting the short-term economic impact for 2016, in Latin America and the Caribbean to be about US$3.5 Billion.

With fears of Zika virus reaching new heights, Zika virus vaccines are gaining popularity. Many Government agencies and research institutes support pharmaceutical companies for the development & manufacturing of Zika virus vaccines. It is predicted that Zika virus vaccines shot will available to the public by 2018.

Request for Proposal @ https://mnemonicsresearch.com/submit-rfp/zika-virus-vaccines-market-0043

The research report presents a comprehensive study of the Zika virus vaccines with details. It provides essential insights of introduction of Zika virus, current situation and areas with Zika virus and funding in Zika virus vaccines research. Additionally, the report includes assessment of clinical trials and regulatory landscape of Zika virus vaccines development. Key trends in terms of partnerships, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the Zika virus vaccines development such as Sanofi Pasteur, ImmunoVaccines Inc, Inovio Pharmaceuticals, Inc, Valneva, Bharat Biotech International Pvt. Ltd., NewLink Genetics. The major players are evaluated on various parameters such as company overview, product outlook and Zika virus vaccines latest development and trends.

Browse Full Report @ https://mnemonicsresearch.com/zika-virus-vaccines-market-0043

This 87 Page report has been analyzed from 7 viewpoints:

1. Zika Virus – Introduction, Signs and Symptoms, Transmission, Diagnosis, Treatment & Prevention
2. Current Situation & Areas with Zika Virus
3. Competitive Landscape of The Zika Virus Vaccines Companies
4. Funding in Zika Virus Vaccines Research
5. Zika Virus Vaccines – Clinical Trials Insight by Phase & Trial Status
6. Zika Virus Vaccines – Regulatory Landscape
7. Key Companies Analysis

Global vaccines market size is expected to exceed US$ 48 Billion by the year–end of 2025

“Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025” presents an in–depth assessment of the global vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for the global vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

FREE | Request an Overview @ https://mnemonicsresearch.com/request-an-overview/vaccines-market-0101

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global vaccines market. The report explores a detailed analysis of the top 42 vaccines market value assessment globally from 2015 to 2018 and forecasts to 2025.

Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisitions, partnerships, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global vaccines market.

The report concludes with the profiles of major players in the global vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolios, promising vaccines in the clinical development, vaccines market value analysis and recent development.

Request for Proposal @ https://mnemonicsresearch.com/submit-rfp/vaccines-market-0101

Long–term Growth Projection:

• Merck acquired Immune Design in 2019
• Shingrix is set to achieve blockbuster vaccine status in 2019
• Prevnar / Prevnar 13 has captured the highest market share of the global vaccines market
• With a market value of more than US$ 7 billion, GSK led the global vaccines market in 2018

Top 42 Vaccines Covered Under This Report Are:

1. Prevnar / Prevnar 13
2. Gardasil / Gardasil 9
3. Vaxigrip
4. Fluzone
5. Flublok
6. Varivax
7. Menactra
8. Proquad
9. Pneumovax 23
10. Fluarix/FluLaval
11. Havrix/Twinrix/Engerix–B
12. Priorix, Priorix Tetra, Varilrix
13. M–M–R II
14. Adacel
15. Boostrix
16. Bexsero
17. Menveo
18. Cervarix
19. Trumenba
20. Shingrix
21. Pentacel, Pentaxim, Imovax, Hexaxim
22. Rotateq
23. Zostavax
24. Rotarix
25. Synflorix
26. Pediarix,Infanrix
27. Ticovac
28. Biken Ha
29. Tetrabik
30. Mearubik
31. Varicella (MTP)
32. Jebik V
33. Flumist/Fluenz
34. Bio Thrax
35. Dukoral
36. Ixiaro
37. In Live
38. HeaLive
39. BiLive
40. Anflu
41. EasySix
42. Imvamune

Browse Full Report @ https://mnemonicsresearch.com/vaccines-market-0101

The major companies dominating this market for its products, services, and continuous product developments are:

1. Sanofi Pasteur
2. GlaxoSmithKline (GSK)
3. Merck
4. Pfizer
5. AstraZeneca
6. Mitsubishi Tanabe Pharma
7. Emergent Biosolutions
8. Astellas Pharma Inc
9. Valneva
10. Seqirus
11. Bavarian Nordic
12. Sinovac
13. Panacea Biotec
14. Bharat Biotech
15. Serum Institute of India
16. Biological E. Limited

The Latest Industry Data Included in this Report:

• Global Vaccines Market Size & Analysis (2015 – 2025)
• Market Share Analysis of Global Vaccines Market (%),2015 – 2025
• Global Vaccines Market Share, By Brand
• Global Vaccines Market Share, By Company
• Global Top 42 Vaccines Market Assessment & Opportunity (Value),2015 – 2025
• Major Companies Vaccines Market Value Analysis & Forecast
• Promising Vaccines in Clinical Development by Major Companies
• Detailed Vaccines Portfolio of the Major Companies
• Major Deals in the Global Vaccines Market
• Key Market Drivers and Inhibitors of the Global Vaccines Market
• Major Companies Analysis

The Report Answers the Following Questions about the Global Vaccines Market:

• What is the size of the global vaccines market during 2015–2025?
• What will be the revenue generated by each vaccine during the forecast period?
• Which vaccine provides the highest market share?
• What are the leading companies dominating the global vaccines market? What is the share of these companies in the global vaccines market?
• How will the industry evolve during the forecast period 2019 – 2025?
• What are the key drivers and inhibitors in the current market?
• What is the key development implemented by the leading players to stand out in this market?
• Who are the key players in this market space?

Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025.

“United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for United States pneumococcal & meningococcal vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

FREE | Request an Overview @ https://mnemonicsresearch.com/request-an-overview/united-states-pneumococcal-and-meningococcal-vaccines-market-0103

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues, and provides forecasts through 2025. The report provides a clear insight into current and future developments of the United States pneumococcal & meningococcal vaccine market. The report also explores detailed analysis of the top 6 vaccine market assessment in the United States from 2015 to 2018 and forecasts to 2025.

The report also details the latest information about the pneumococcal & meningococcal vaccine pricing trends and analysis. It also covers reimbursement patterns and offers a clear view of the regulatory landscape. Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive, licensing agreement, and partnerships are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States pneumococcal & meningococcal vaccine market.

The report concludes with the profiles of major players in the United States pneumococcal & meningococcal vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolio, and recent development.

Request for Proposal @ https://mnemonicsresearch.com/submit-rfp/united-states-pneumococcal-and-meningococcal-vaccines-market-0103

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline (GSK)

Top 6 Vaccines Covered Under This Report Are:
• Prevnar / Prevnar 13
• Pneumovax 23
• Menactra
• Bexsero
• Menveo
• Trumenba

The Latest Industry Data Included in this Report:

• United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
​• United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
• United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025
• United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
• United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025
• United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
• United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies
• United States Pneumococcal & Meningococcal Vaccines Regulatory System
• Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
• Major Deals in the Vaccines Market
• Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
• Major Companies Analysis

Browse Full Report @ https://mnemonicsresearch.com/united-states-pneumococcal-and-meningococcal-vaccines-market-0103

The Report Answers the Following Questions about the United States Pneumococcal & Meningococcal Vaccines Market:
• What is the size of the United States pneumococcal & meningococcal vaccines market during 2015 – 2025?
• What will be the revenue generated by each vaccine during the forecast period?
• Which vaccine provides the highest market share?
• How are the overall market and vaccines type growing?
• What are the key drivers and inhibitors in the current market?
• What are the various pneumococcal & meningococcal vaccines available in the United States?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?